Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $9.31 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 49.24.
Market Cap
9.31T
Revenue
4.67T
Profits
189.01B
PE Ratio
49.24
Profit Margin
4.05%
Dividend Yield
0.38%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | 0.41% | 1,229,653 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 646.67B | -0.42% | 2,236,995 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 468.52B | 0.25% | 1,041,196 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 374.06B | 1.41% | 4,339,294 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 335.46B | -1.01% | 1,959,695 | 450.53B |
| 6 | NVS | Novartis AG | 268.82B | 0.10% | 886,217 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 260.49B | 0.13% | 1,157,218 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 243.62B | 0.02% | 891,334 | 46.34B |
| 9 | AMGN | Amgen Inc. | 220.86B | 3.91% | 2,113,546 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 189.64B | 1.58% | 1,713,000 | 30.46B |
| 11 | ABT | Abbott Laboratories | 180.32B | 1.19% | 3,177,541 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 176.42B | -0.84% | 15,787,511 | 50.34B |
| 13 | PFE | Pfizer Inc. | 158.65B | 0.34% | 13,324,943 | 63.70B |
| 14 | DHR | Danaher Corporation | 155.64B | 2.58% | 1,909,903 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.51B | -0.27% | 702,781 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 132.14B | 2.08% | 624,653 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.83B | -0.06% | 2,485,317 | 49.19B |
| 18 | MDT | Medtronic plc | 117.07B | -0.25% | 5,861,927 | 37.54B |
| 19 | CVS | CVS Health Corporation | 111.97B | -0.06% | 3,321,132 | 412.65B |
| 20 | SYK | Stryker Corporation | 105.99B | 0.78% | 783,784 | 25.84B |
| 21 | MCK | McKesson Corporation | 104.29B | 0.90% | 205,766 | 410.98B |
| 22 | SNY | Sanofi | 101.98B | -0.07% | 1,730,297 | 55.89B |
| 23 | GSK | GSK plc | 101.90B | -0.80% | 2,719,634 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 94.83B | 2.82% | 496,286 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 87.50B | -1.43% | 362,444 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.68B | 1.22% | 275,346 | 15.53B |
| 27 | MRNA | Moderna, Inc. | 72.90B | 5.58% | 17,860,683 | 2.23B |
| 28 | CI | The Cigna Group | 72.56B | 0.05% | 453,937 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 64.83B | 2.32% | 6,816,269 | 21.00B |
| 30 | ARGX | argenx SE | 62.26B | -1.56% | 154,850 | 5.32B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.71B | 0.48% | 855,562 | 28.42B |
| 32 | COR | Cencora, Inc. | 60.39B | -0.02% | 235,620 | 332.77B |
| 33 | NTRA | Natera, Inc. | 56.13B | 5.07% | 695,719 | 2.71B |
| 34 | CAH | Cardinal Health, Inc. | 52.40B | 0.23% | 588,064 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 51.44B | 1.02% | 1,436,130 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 49.62B | 0.80% | 511,740 | 22.48B |
| 37 | A | Agilent Technologies, Inc. | 46.75B | 2.40% | 1,212,038 | 7.37B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 45.67B | -2.17% | 2,528,079 | 17.32B |
| 39 | HUM | Humana Inc. | 44.84B | -1.36% | 324,395 | 145.68B |
| 40 | MDLN | Medline Inc. | 44.63B | 6.21% | 3,391,116 | 29.94B |
| 41 | IQV | IQVIA Holdings Inc. | 44.60B | 0.40% | 258,272 | 16.98B |
| 42 | VEEV | Veeva Systems Inc. | 42.82B | 1.21% | 449,257 | 3.46B |
| 43 | WAT | Waters Corporation | 42.01B | 0.87% | 285,551 | 4.64B |
| 44 | ONC | BeOne Medicines AG | 41.28B | -0.71% | 131,700 | 6.13B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 41.17B | 1.40% | 232,274 | 4.55B |
| 46 | RVMD | Revolution Medicines, Inc. | 41.11B | -0.49% | 559,670 | - |
| 47 | HLN | Haleon plc | 40.38B | -1.01% | 20,437,650 | 14.80B |
| 48 | ILMN | Illumina, Inc. | 37.19B | 3.13% | 799,930 | 4.49B |
| 49 | DXCM | DexCom, Inc. | 33.93B | 0.84% | 3,262,465 | 4.97B |
| 50 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.80B | 3.38% | 497,414 | 4.80B |
| 51 | RPRX | Royalty Pharma plc | 33.64B | 0.10% | 965,740 | 2.54B |
| 52 | BIIB | Biogen Inc. | 33.13B | 2.36% | 405,920 | 10.03B |
| 53 | RMD | ResMed Inc. | 32.15B | 0.51% | 216,238 | 5.65B |
| 54 | ALC | Alcon Inc. | 31.50B | 0.86% | 505,796 | 10.86B |
| 55 | CNC | Centene Corporation | 31.41B | -2.15% | 2,155,883 | 180.30B |
| 56 | ZTS | Zoetis Inc. | 29.96B | 1.66% | 1,509,987 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 29.84B | 1.94% | 1,885,712 | 21.27B |
| 58 | MTD | Mettler-Toledo International Inc. | 29.70B | 3.63% | 87,926 | 4.13B |
| 59 | ROIV | Roivant Sciences Ltd. | 27.65B | -1.82% | 1,903,629 | 7.53M |
| 60 | WST | West Pharmaceutical Services, Inc. | 26.21B | 2.96% | 294,874 | 3.33B |
| 61 | INSM | Insmed Incorporated | 26.17B | -0.95% | 742,132 | 1.14B |
| 62 | DGX | Quest Diagnostics Incorporated | 25.88B | -4.24% | 1,750,376 | 11.56B |
| 63 | INCY | Incyte Corporation | 25.61B | 1.37% | 499,273 | 5.82B |
| 64 | LH | Labcorp Holdings Inc. | 25.45B | -2.23% | 590,207 | 14.35B |
| 65 | BNTX | BioNTech SE | 25.24B | 2.51% | 450,721 | 3.03B |
| 66 | PHG | Koninklijke Philips N.V. | 24.35B | 0.16% | 246,545 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 23.82B | 2.11% | 885,797 | 1.18B |
| 68 | THC | Tenet Healthcare Corporation | 21.21B | 0.94% | 123,565 | 21.81B |
| 69 | UTHR | United Therapeutics Corporation | 21.20B | 0.24% | 128,025 | 3.15B |
| 70 | GMAB | Genmab A/S | 20.72B | 1.12% | 1,350,005 | 4.13B |
| 71 | STE | STERIS plc | 20.26B | 0.41% | 192,469 | 6.04B |
| 72 | VTRS | Viatris Inc. | 19.63B | -0.06% | 1,724,641 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.94B | -0.28% | 449,226 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.59B | 0.97% | 131,766 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 15.99B | -0.21% | 763,285 | 2.91B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.63B | -0.30% | 142,106 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 15.55B | -0.32% | 227,706 | 1.20B |
| 78 | SOLV | Solventum Corporation | 15.15B | 0.20% | 185,460 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.53B | -0.68% | 473,347 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.46B | 1.99% | 611,006 | 2.44B |
| 81 | TEM | Tempus AI, Inc. | 14.03B | -0.38% | 4,006,550 | 1.43B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.79B | 3.54% | 462,284 | 4.00B |
| 83 | SMMT | Summit Therapeutics Inc. | 13.60B | 0.89% | 2,050,881 | - |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.49B | 3.68% | 1,429,830 | 713.07M |
| 85 | ICLR | ICON Public Limited Company | 13.07B | -0.12% | 444,267 | 8.29B |
| 86 | HALO | Halozyme Therapeutics, Inc. | 12.90B | 1.95% | 790,116 | 1.66B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.72B | 3.46% | 221,076 | 830.81M |
| 88 | PEN | Penumbra, Inc. | 12.56B | 0.06% | 440,180 | 1.50B |
| 89 | BMRN | BioMarin Pharmaceutical Inc. | 12.39B | -0.09% | 798,187 | 3.41B |
| 90 | BAX | Baxter International Inc. | 12.30B | 3.75% | 2,875,579 | 11.47B |
| 91 | EHC | Encompass Health Corporation | 12.26B | 2.21% | 291,878 | 6.21B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.11B | 0.44% | 122,531 | 1.28B |
| 93 | FMS | Fresenius Medical Care AG | 11.81B | 1.55% | 404,194 | 22.19B |
| 94 | BTSG | BrightSpring Health Services, Inc. | 11.75B | 0.95% | 605,073 | 14.37B |
| 95 | DVA | DaVita Inc. | 11.73B | 0.87% | 153,031 | 14.01B |
| 96 | SNN | Smith & Nephew plc | 11.63B | -0.72% | 423,472 | 6.30B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.48B | 2.45% | 2,146,080 | 5.02B |
| 98 | TECH | Bio-Techne Corporation | 11.39B | 0.25% | 2,450,206 | 1.22B |
| 99 | ALGN | Align Technology, Inc. | 10.82B | 3.66% | 331,552 | 4.14B |
| 100 | AXSM | Axsome Therapeutics, Inc. | 10.75B | -0.08% | 85,893 | 776.57M |
| 101 | TXG | 10x Genomics, Inc. | 10.72B | 4.06% | 1,955,505 | 616.91M |
| 102 | UHS | Universal Health Services, Inc. | 10.58B | 2.76% | 276,768 | 18.11B |
| 103 | RGEN | Repligen Corporation | 10.55B | 3.41% | 569,661 | 785.10M |
| 104 | RDY | Dr. Reddy's Laboratories Limited | 10.54B | 1.61% | 1,432,948 | 3.50B |
| 105 | TWST | Twist Bioscience Corporation | 10.52B | 1.13% | 1,282,055 | 431.80M |
| 106 | COO | The Cooper Companies, Inc. | 10.49B | 1.96% | 897,620 | 4.24B |
| 107 | KRYS | Krystal Biotech, Inc. | 10.26B | 3.88% | 99,644 | 440.48M |
| 108 | AVTR | Avantor, Inc. | 10.24B | 0.26% | 4,007,420 | 6.56B |
| 109 | ENSG | The Ensign Group, Inc. | 10.23B | 1.47% | 137,199 | 5.49B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 10.17B | 0.76% | 194,271 | 2.59B |
| 111 | GMED | Globus Medical, Inc. | 10.10B | 1.24% | 765,536 | 3.14B |
| 112 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.09B | 3.87% | 1,099,245 | 669.50M |
| 113 | KYMR | Kymera Therapeutics, Inc. | 10.06B | 2.78% | 233,053 | 105.00M |
| 114 | MOH | Molina Healthcare, Inc. | 9.98B | -3.14% | 172,001 | 42.47B |
| 115 | IBRX | ImmunityBio, Inc. | 9.96B | 11.24% | 9,353,599 | 165.79M |
| 116 | HSIC | Henry Schein, Inc. | 9.71B | 2.30% | 326,235 | 13.60B |
| 117 | PODD | Insulet Corporation | 9.69B | -0.56% | 467,989 | 3.05B |
| 118 | GKOS | Glaukos Corporation | 9.51B | -0.15% | 537,037 | 612.84M |
| 119 | CYTK | Cytokinetics, Incorporated | 9.47B | 0.78% | 853,231 | 67.67M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.39B | 0.06% | 263,509 | 281.99M |
| 121 | BRKR | Bruker Corporation | 9.37B | -0.08% | 727,969 | 3.50B |
| 122 | OSCR | Oscar Health, Inc. | 9.27B | -3.87% | 4,169,607 | 15.32B |
| 123 | ABVX | ABIVAX Société Anonyme | 9.06B | -4.19% | 1,678,894 | 5.80M |
| 124 | QGEN | Qiagen N.V. | 9.06B | -2.19% | 715,198 | 2.10B |
| 125 | CAI | Caris Life Sciences, Inc. | 8.99B | 3.82% | 2,996,060 | 989.61M |
| 126 | PCVX | Vaxcyte, Inc. | 8.82B | 0.61% | 561,846 | - |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 8.40B | 0.71% | 352,045 | 7.46M |
| 128 | TGTX | TG Therapeutics, Inc. | 8.19B | 1.07% | 768,241 | 799.54M |
| 129 | SYRE | Spyre Therapeutics, Inc. | 8.04B | -0.86% | 304,302 | - |
| 130 | ATR | AptarGroup, Inc. | 7.96B | 1.43% | 126,440 | 3.93B |
| 131 | IMVT | Immunovant, Inc. | 7.69B | 0.19% | 473,054 | - |
| 132 | HQY | HealthEquity, Inc. | 7.66B | -1.97% | 322,438 | 1.36B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.53B | 0.98% | 1,976,753 | 874.09M |
| 134 | HNGE | Hinge Health, Inc. | 7.53B | -1.16% | 338,053 | 720.06M |
| 135 | ALKS | Alkermes plc | 7.42B | 0.05% | 757,049 | 1.67B |
| 136 | HIMS | Hims & Hers Health, Inc. | 7.30B | 6.64% | 8,713,738 | 2.58B |
| 137 | BLTE | Belite Bio, Inc | 7.05B | 0.92% | 158,801 | - |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.92B | 1.75% | 140,224 | 239.92M |
| 139 | CGON | CG Oncology, Inc. | 6.81B | -1.81% | 645,116 | 6.23M |
| 140 | AMRX | Amneal Pharmaceuticals, Inc. | 6.71B | -4.46% | 1,409,406 | 3.12B |
| 141 | PACS | PACS Group, Inc. | 6.64B | -0.31% | 240,848 | 5.55B |
| 142 | GRFS | Grifols, S.A. | 6.56B | 0.68% | 442,931 | 8.48B |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.55B | 0.03% | 753,910 | 1.56B |
| 144 | CHE | Chemed Corporation | 6.51B | 0.10% | 45,441 | 2.60B |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.19B | 0.15% | 315,825 | - |
| 146 | BLCO | Bausch + Lomb Corporation | 6.16B | 2.62% | 122,100 | 5.32B |
| 147 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.12B | 0.41% | 162,256 | 840.85M |
| 148 | SRRK | Scholar Rock Holding Corporation | 6.11B | 4.22% | 1,331,308 | - |
| 149 | LQDA | Liquidia Corporation | 6.04B | 1.54% | 242,054 | 450.91M |
| 150 | MMED | MiniMed Group, Inc. | 5.92B | -0.38% | 1,008,980 | 3.22B |
| 151 | STVN | Stevanato Group S.p.A. | 5.92B | 0.70% | 78,318 | 1.40B |
| 152 | MIRM | Mirum Pharmaceuticals, Inc. | 5.91B | -1.03% | 191,807 | 618.07M |
| 153 | LGND | Ligand Pharmaceuticals Incorporated | 5.82B | 0.67% | 76,192 | 290.54M |
| 154 | RDNT | RadNet, Inc. | 5.75B | 0.62% | 318,266 | 2.27B |
| 155 | TVTX | Travere Therapeutics, Inc. | 5.72B | -3.54% | 1,316,213 | 591.33M |
| 156 | COGT | Cogent Biosciences, Inc. | 5.64B | 1.47% | 963,764 | - |
| 157 | CRSP | CRISPR Therapeutics AG | 5.58B | -1.15% | 894,210 | 13.39M |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.52B | 1.26% | 466,250 | 1.01B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.51B | 2.08% | 319,268 | 1.90M |
| 160 | BLLN | BillionToOne, Inc. | 5.48B | 11.91% | 721,326 | 397.41M |
| 161 | ERAS | Erasca, Inc. | 5.41B | 2.86% | 1,237,053 | - |
| 162 | SHC | Sotera Health Company | 5.37B | 0.70% | 444,114 | 1.22B |
| 163 | TFX | Teleflex Incorporated | 5.31B | 0.36% | 272,222 | 2.25B |
| 164 | DFTX | Definium Therapeutics, Inc. | 5.28B | 0.03% | 632,726 | - |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.21B | 2.09% | 276,758 | 1.58B |
| 166 | HAE | Haemonetics Corporation | 4.96B | 0.28% | 123,297 | 1.35B |
| 167 | EWTX | Edgewise Therapeutics, Inc. | 4.92B | 1.57% | 967,522 | - |
| 168 | MANE | Veradermics, Incorporated | 4.90B | 4.03% | 1,097,553 | - |
| 169 | WAY | Waystar Holding Corp. | 4.87B | -1.21% | 538,108 | 1.21B |
| 170 | LFST | LifeStance Health Group, Inc. | 4.86B | 0.32% | 1,537,324 | 1.58B |
| 171 | IOVA | Iovance Biotherapeutics, Inc. | 4.83B | 4.66% | 7,416,764 | 324.97M |
| 172 | GRAL | GRAIL, Inc. | 4.80B | -0.44% | 904,931 | 165.26M |
| 173 | DOCS | Doximity, Inc. | 4.78B | -0.11% | 740,640 | 655.57M |
| 174 | PBLS | Parabilis Medicines, Inc. | 4.65B | 2.03% | 447,114 | 148.00K |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 4.56B | 0.28% | 481,821 | 1.14B |
| 176 | VKTX | Viking Therapeutics, Inc. | 4.52B | 28.60% | 33,164,411 | - |
| 177 | ADPT | Adaptive Biotechnologies Corporation | 4.47B | 0.47% | 2,341,287 | 308.08M |
| 178 | CON | Concentra Group Holdings Parent, Inc. | 4.46B | 0.69% | 195,234 | 2.29B |
| 179 | HTFL | HeartFlow, Inc. | 4.36B | -0.36% | 539,817 | 212.07M |
| 180 | LIVN | LivaNova PLC | 4.34B | 0.86% | 239,640 | 1.47B |
| 181 | ITGR | Integer Holdings Corporation | 4.30B | 0.02% | 243,864 | 1.84B |
| 182 | INDV | Indivior Pharmaceuticals, Inc. | 4.25B | 1.41% | 655,511 | 1.33B |
| 183 | ABCL | AbCellera Biologics Inc. | 4.15B | 1.11% | 2,718,934 | 66.17M |
| 184 | CELC | Celcuity Inc. | 4.10B | -0.29% | 184,531 | - |
| 185 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.10B | 0.74% | 533,574 | -665.00K |
| 186 | TLX | Telix Pharmaceuticals Limited | 4.06B | 5.57% | 397,607 | 890.79M |
| 187 | RLAY | Relay Therapeutics, Inc. | 4.06B | 1.87% | 1,179,253 | 10.35M |
| 188 | TNGX | Tango Therapeutics, Inc. | 4.05B | 7.48% | 2,330,219 | 53.81M |
| 189 | ICUI | ICU Medical, Inc. | 3.98B | 2.43% | 95,067 | 2.16B |
| 190 | NVST | Envista Holdings Corporation | 3.91B | 3.80% | 1,648,540 | 2.86B |
| 191 | IDYA | IDEAYA Biosciences, Inc. | 3.81B | 1.67% | 321,426 | 234.13M |
| 192 | PLSE | Pulse Biosciences, Inc. | 3.79B | -0.24% | 134,072 | 1.19M |
| 193 | XENE | Xenon Pharmaceuticals Inc. | 3.75B | -0.72% | 1,156,052 | 7.50M |
| 194 | IRTC | iRhythm Holdings, Inc. | 3.65B | 0.40% | 156,637 | 825.34M |
| 195 | OPCH | Option Care Health, Inc. | 3.64B | 1.42% | 614,386 | 5.69B |
| 196 | OGN | Organon & Co. | 3.60B | 0.11% | 519,249 | 6.13B |
| 197 | LEGN | Legend Biotech Corporation | 3.59B | 0.11% | 1,296,224 | 1.27B |
| 198 | ELVN | Enliven Therapeutics, Inc. | 3.51B | -2.01% | 523,106 | - |
| 199 | VCYT | Veracyte, Inc. | 3.47B | 3.93% | 550,224 | 561.90M |
| 200 | NHC | National HealthCare Corporation | 3.46B | -0.94% | 36,745 | 1.56B |
| 201 | ARQT | Arcutis Biotherapeutics, Inc. | 3.45B | 5.66% | 1,062,320 | 463.98M |
| 202 | DNLI | Denali Therapeutics Inc. | 3.43B | 4.69% | 993,206 | 3.60M |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.38B | -0.51% | 215,651 | 606.33M |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.38B | 2.20% | 452,957 | 117.00M |
| 205 | DYN | Dyne Therapeutics, Inc. | 3.24B | 1.34% | 862,211 | - |
| 206 | QURE | uniQure N.V. | 3.09B | 0.61% | 434,046 | 18.67M |
| 207 | TMDX | TransMedics Group, Inc. | 3.08B | 1.72% | 340,301 | 668.47M |
| 208 | RGC | Regencell Bioscience Holdings Limited | 3.07B | 4.73% | 72,310 | - |
| 209 | ATRC | AtriCure, Inc. | 3.01B | 1.63% | 385,665 | 569.62M |
| 210 | NEOG | Neogen Corporation | 3.00B | 1.18% | 2,285,869 | 870.40M |
| 211 | ZLAB | Zai Lab Limited | 2.99B | 0.76% | 420,714 | 449.61M |
| 212 | MBX | MBX Biosciences, Inc. | 2.94B | 0.10% | 161,957 | - |
| 213 | CDNA | CareDx, Inc. | 2.92B | 3.73% | 586,379 | 458.09M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.88B | -1.67% | 1,135,582 | 2.60B |
| 215 | WRBY | Warby Parker Inc. | 2.88B | 0.30% | 1,075,745 | 911.61M |
| 216 | IMNM | Immunome, Inc. | 2.88B | 1.00% | 444,853 | 4.02M |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.86B | 2.24% | 121,147 | 1.46B |
| 218 | PGEN | Precigen, Inc. | 2.82B | 2.47% | 2,571,961 | 85.72M |
| 219 | NAMS | NewAmsterdam Pharma Company N.V. | 2.79B | 3.41% | 996,911 | 7.12M |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.74B | 3.67% | 460,820 | 3.37B |
| 221 | BKD | Brookdale Senior Living Inc. | 2.72B | 0.04% | 2,430,302 | 2.93B |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.69B | -9.45% | 9,359,756 | 158.00K |
| 223 | NRIX | Nurix Therapeutics, Inc. | 2.66B | 0.98% | 721,848 | 36.77M |
| 224 | AXGN | Axogen, Inc. | 2.65B | -1.59% | 498,966 | 251.17M |
| 225 | IRON | Disc Medicine, Inc. | 2.63B | 0.12% | 194,071 | - |
| 226 | WGS | GeneDx Holdings Corp. | 2.63B | -9.84% | 1,024,866 | 454.43M |
| 227 | GPCR | Structure Therapeutics Inc. | 2.60B | -1.09% | 198,661 | - |
| 228 | BFLY | Butterfly Network, Inc. | 2.60B | 19.78% | 11,584,134 | 112.14M |
| 229 | BEAM | Beam Therapeutics Inc. | 2.59B | 2.61% | 992,274 | 156.04M |
| 230 | VERA | Vera Therapeutics, Inc. | 2.59B | 4.93% | 925,296 | - |
| 231 | MLYS | Mineralys Therapeutics, Inc. | 2.57B | 2.76% | 358,885 | - |
| 232 | HCM | HUTCHMED (China) Limited | 2.52B | -2.62% | 16,941 | 549.12M |
| 233 | SUPN | Supernus Pharmaceuticals, Inc. | 2.52B | 1.40% | 367,676 | 830.44M |
| 234 | PRVA | Privia Health Group, Inc. | 2.52B | 1.02% | 309,289 | 2.36B |
| 235 | VRDN | Viridian Therapeutics, Inc. | 2.48B | 1.55% | 577,422 | 71.13M |
| 236 | PHVS | Pharvaris N.V. | 2.47B | -2.19% | 265,420 | - |
| 237 | NEO | NeoGenomics, Inc. | 2.46B | -1.44% | 741,575 | 766.30M |
| 238 | HRMY | Harmony Biosciences Holdings, Inc. | 2.44B | -0.33% | 154,556 | 959.90M |
| 239 | CLOV | Clover Health Investments, Corp. | 2.42B | 0.22% | 1,747,573 | 2.48B |
| 240 | SLS | SELLAS Life Sciences Group, Inc. | 2.38B | 3.78% | 3,518,938 | - |
| 241 | ALMR | Alamar Biosciences, Inc. | 2.34B | -3.92% | 151,384 | 100.42M |
| 242 | TRLV | Trulieve Cannabis Corp. | 2.31B | 4.26% | 1,662,181 | 1.14B |
| 243 | OCUL | Ocular Therapeutix, Inc. | 2.30B | 4.90% | 769,855 | 52.06M |
| 244 | NKTR | Nektar Therapeutics | 2.30B | 0.79% | 397,282 | 54.59M |
| 245 | SDGR | Schrödinger, Inc. | 2.29B | 1.39% | 1,589,015 | 259.04M |
| 246 | PVLA | Palvella Therapeutics, Inc. | 2.29B | 3.39% | 136,727 | - |
| 247 | GENB | Generate Biomedicines, Inc. | 2.25B | 1.04% | 535,257 | 26.48M |
| 248 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.25B | 0.57% | 996,906 | 940.61M |
| 249 | PBH | Prestige Consumer Healthcare Inc. | 2.23B | 0.66% | 198,368 | 1.10B |
| 250 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | 0.66% | 237,446 | 311.51M |
| 251 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | 3.57% | 676,322 | 1.97B |
| 252 | RXRX | Recursion Pharmaceuticals, Inc. | 2.20B | 3.40% | 22,715,652 | 54.86M |
| 253 | BHVN | Biohaven Ltd. | 2.20B | 2.25% | 1,022,049 | - |
| 254 | UFPT | UFP Technologies, Inc. | 2.19B | 0.47% | 49,599 | 631.64M |
| 255 | ADMA | ADMA Biologics, Inc. | 2.18B | 2.26% | 1,065,041 | 512.28M |
| 256 | TRVI | Trevi Therapeutics, Inc. | 2.16B | 1.61% | 495,044 | - |
| 257 | BHC | Bausch Health Companies Inc. | 2.15B | 2.04% | 739,180 | 10.85B |
| 258 | ADUS | Addus HomeCare Corporation | 2.13B | 0.96% | 38,091 | 1.48B |
| 259 | NUVB | Nuvation Bio Inc. | 2.13B | -0.08% | 1,804,206 | 169.90M |
| 260 | ESTA | Establishment Labs Holdings Inc. | 2.12B | 5.24% | 130,784 | 245.82M |
| 261 | KOD | Kodiak Sciences Inc. | 2.11B | 3.86% | 353,741 | - |
| 262 | INSP | Inspire Medical Systems, Inc. | 2.10B | -4.05% | 419,348 | 898.74M |
| 263 | ZBIO | Zenas BioPharma, Inc. | 2.10B | -1.01% | 177,781 | 1.00M |
| 264 | ALVO | Alvotech | 2.09B | -0.34% | 669,292 | 494.61M |
| 265 | MD | Pediatrix Medical Group, Inc. | 2.09B | 2.21% | 264,375 | 1.95B |
| 266 | URGN | UroGen Pharma Ltd. | 2.09B | -1.09% | 154,772 | 188.73M |
| 267 | AGIO | Agios Pharmaceuticals, Inc. | 2.07B | 2.14% | 377,495 | 98.34M |
| 268 | CMPS | COMPASS Pathways plc | 2.06B | -0.73% | 1,341,390 | - |
| 269 | VCEL | Vericel Corporation | 2.05B | 1.34% | 234,584 | 306.30M |
| 270 | PGNY | Progyny, Inc. | 2.04B | -0.95% | 317,761 | 1.31B |
| 271 | MESO | Mesoblast Limited | 2.00B | 2.26% | 90,593 | 120.25M |
| 272 | SGRY | Surgery Partners, Inc. | 2.00B | 12.66% | 3,764,787 | 3.37B |
| 273 | PRGO | Perrigo Company plc | 1.98B | 0.99% | 731,617 | 4.14B |
| 274 | XRAY | DENTSPLY SIRONA Inc. | 1.97B | 4.50% | 2,039,994 | 3.64B |
| 275 | NVCR | NovoCure Limited | 1.94B | 1.03% | 224,672 | 699.19M |
| 276 | FTRE | Fortrea Holdings Inc. | 1.93B | 1.62% | 380,233 | 2.68B |
| 277 | ZYME | Zymeworks Inc. | 1.93B | 1.49% | 167,560 | 37.13M |
| 278 | VIR | Vir Biotechnology, Inc. | 1.91B | 3.95% | 527,063 | 303.23M |
| 279 | LKFT | Lakefront Biotherapeutics NV | 1.91B | 2.20% | 278,179 | 1.13B |
| 280 | GHRS | GH Research PLC | 1.90B | -0.64% | 38,921 | - |
| 281 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.89B | 1.60% | 581,362 | 208.78M |
| 282 | RAPP | Rapport Therapeutics, Inc. | 1.87B | -1.75% | 332,868 | 20.00M |
| 283 | ABSI | Absci Corporation | 1.87B | 10.69% | 4,853,660 | 1.56M |
| 284 | BLFS | BioLife Solutions, Inc. | 1.86B | 2.47% | 428,132 | 106.69M |
| 285 | XNCR | Xencor, Inc. | 1.86B | -0.32% | 627,448 | 104.97M |
| 286 | SEPN | Septerna, Inc. | 1.85B | 2.67% | 109,790 | 98.88M |
| 287 | STOK | Stoke Therapeutics, Inc. | 1.85B | 2.00% | 111,634 | 27.59M |
| 288 | LMAT | LeMaitre Vascular, Inc. | 1.84B | 1.70% | 59,137 | 262.43M |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.82B | 0.60% | 99,484 | 481.07M |
| 290 | COAG | Hemab Therapeutics Holdings, Inc. | 1.81B | 2.19% | 259,143 | - |
| 291 | NVAX | Novavax, Inc. | 1.80B | 4.56% | 5,079,711 | 413.80M |
| 292 | FRNM | Freenome, Inc. | 1.79B | 0.57% | 327,861 | 35.41M |
| 293 | NTLA | Intellia Therapeutics, Inc. | 1.77B | 3.40% | 2,306,675 | 59.51M |
| 294 | PSNL | Personalis, Inc. | 1.75B | 1.17% | 611,348 | 69.67M |
| 295 | ASTH | Astrana Health, Inc. | 1.75B | 1.94% | 92,671 | 3.84B |
| 296 | TYRA | Tyra Biosciences, Inc. | 1.74B | -1.60% | 298,465 | - |
| 297 | NBTX | Nanobiotix S.A. | 1.73B | 1.54% | 29,165 | 38.27M |
| 298 | TSHA | Taysha Gene Therapies, Inc. | 1.67B | 1.88% | 920,211 | 5.49M |
| 299 | ALHC | Alignment Healthcare, Inc. | 1.67B | -3.60% | 4,863,748 | 4.58B |
| 300 | INBX | Inhibrx Biosciences, Inc. | 1.66B | 0.60% | 166,623 | 1.30M |
| 301 | IMCR | Immunocore Holdings plc | 1.66B | -0.06% | 109,181 | 430.78M |
| 302 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | -2.31% | 140,907 | 978.38M |
| 303 | ETON | Eton Pharmaceuticals, Inc. | 1.62B | 2.69% | 131,180 | 105.60M |
| 304 | SNDX | Syndax Pharmaceuticals, Inc. | 1.61B | 0.06% | 614,567 | 252.25M |
| 305 | XERS | Xeris Biopharma Holdings, Inc. | 1.61B | 0.11% | 721,158 | 335.41M |
| 306 | ATEC | Alphatec Holdings, Inc. | 1.60B | 1.97% | 447,159 | 815.05M |
| 307 | KLRA | Kailera Therapeutics, Inc. | 1.58B | 1.83% | 608,963 | - |
| 308 | ANAB | AnaptysBio, Inc. | 1.56B | -5.15% | 430,272 | 232.39M |
| 309 | BRVE | Braveheart Bio, Inc. | 1.56B | -3.08% | 345,319 | - |
| 310 | RARE | Ultragenyx Pharmaceutical Inc. | 1.55B | 7.78% | 4,762,293 | 717.00M |
| 311 | KMTS | Kestra Medical Technologies, Ltd. | 1.54B | 4.22% | 115,917 | 106.73M |
| 312 | ARDT | Ardent Health, Inc. | 1.54B | 2.69% | 102,029 | 6.41B |
| 313 | INVA | Innoviva, Inc. | 1.53B | 0.38% | 194,322 | 440.00M |
| 314 | KARD | Kardigan, Inc. | 1.53B | 0.06% | 133,658 | - |
| 315 | OMCL | Omnicell, Inc. | 1.51B | 2.16% | 130,116 | 1.25B |
| 316 | KRSA | Korsana Biosciences, Inc. | 1.50B | -0.66% | 9,187 | - |
| 317 | MAZE | Maze Therapeutics, Inc. | 1.50B | 20.77% | 2,163,716 | 20.00M |
| 318 | OMER | Omeros Corporation | 1.50B | 12.17% | 2,312,232 | 38.42M |
| 319 | AZTA | Azenta, Inc. | 1.50B | 1.51% | 284,706 | 613.81M |
| 320 | BCAX | Bicara Therapeutics Inc. | 1.50B | 2.77% | 143,093 | - |
| 321 | AVBP | ArriVent BioPharma, Inc. | 1.49B | 1.77% | 160,520 | - |
| 322 | AGL | agilon health, inc. | 1.48B | -0.09% | 156,751 | 5.92B |
| 323 | AAPG | Ascentage Pharma Group International | 1.47B | - | 281 | 94.61M |
| 324 | HCSG | Healthcare Services Group, Inc. | 1.47B | 0.54% | 182,610 | 1.86B |
| 325 | TRAX | First Tracks Biotherapeutics, Inc. | 1.46B | 4.92% | 324,667 | - |
| 326 | INNV | InnovAge Holding Corp. | 1.45B | 0.47% | 90,498 | 989.71M |
| 327 | PAHC | Phibro Animal Health Corporation | 1.43B | 1.73% | 35,329 | 1.52B |
| 328 | NUTX | Nutex Health Inc. | 1.41B | 2.23% | 64,696 | 846.72M |
| 329 | LTGO | Latigo Biotherapeutics, Inc. | 1.40B | 0.14% | 132,197 | - |
| 330 | DRTS | Alpha Tau Medical Ltd. | 1.40B | -2.39% | 198,842 | - |
| 331 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | 1.64% | 423,156 | - |
| 332 | AVLN | Avalyn Pharma Inc. | 1.39B | -1.01% | 48,767 | - |
| 333 | PNTG | The Pennant Group, Inc. | 1.38B | 1.73% | 59,034 | 1.10B |
| 334 | DMRA | Damora Therapeutics, Inc. | 1.38B | -2.49% | 148,357 | - |
| 335 | CNMD | CONMED Corporation | 1.37B | 2.34% | 154,528 | 1.37B |
| 336 | SVRA | Savara Inc. | 1.37B | -1.28% | 538,739 | - |
| 337 | ORIC | ORIC Pharmaceuticals, Inc. | 1.36B | 3.87% | 568,905 | - |
| 338 | LBRX | LB Pharmaceuticals Inc | 1.35B | -2.70% | 85,399 | - |
| 339 | VOR | Vor Biopharma Inc. | 1.34B | 3.52% | 1,374,276 | - |
| 340 | CERT | Certara, Inc. | 1.34B | 2.82% | 591,676 | 421.75M |
| 341 | AMN | AMN Healthcare Services, Inc. | 1.33B | 0.26% | 118,814 | 3.43B |
| 342 | OMDA | Omada Health, Inc. | 1.31B | 3.47% | 555,667 | 309.76M |
| 343 | HROW | Harrow, Inc. | 1.28B | 0.99% | 133,807 | 275.59M |
| 344 | OPK | OPKO Health, Inc. | 1.28B | 1.18% | 2,245,835 | 587.90M |
| 345 | REPL | Replimune Group, Inc. | 1.27B | 4.51% | 581,459 | - |
| 346 | USPH | U.S. Physical Therapy, Inc. | 1.25B | 1.58% | 71,388 | 804.27M |
| 347 | IART | Integra LifeSciences Holdings Corporation | 1.24B | 2.05% | 273,247 | 1.65B |
| 348 | CRON | Cronos Group Inc. | 1.22B | 3.30% | 422,212 | 179.09M |
| 349 | BBNX | Beta Bionics, Inc. | 1.22B | 4.99% | 482,874 | 119.01M |
| 350 | AKTS | Aktis Oncology, Inc. | 1.21B | 1.82% | 98,265 | 10.06M |
| 351 | MGTX | MeiraGTx Holdings plc | 1.20B | -4.66% | 642,398 | 397.50M |
| 352 | IMTX | Immatics N.V. | 1.20B | 0.34% | 260,807 | 47.65M |
| 353 | ANRO | Alto Neuroscience, Inc. | 1.19B | -0.69% | 82,959 | - |
| 354 | TNDM | Tandem Diabetes Care, Inc. | 1.19B | -2.72% | 639,462 | 1.04B |
| 355 | GDRX | GoodRx Holdings, Inc. | 1.16B | 0.59% | 432,190 | 785.23M |
| 356 | AORT | Artivion, Inc. | 1.16B | 0.38% | 169,361 | 471.47M |
| 357 | SPTX | Seaport Therapeutics, Inc. | 1.15B | 2.13% | 48,267 | - |
| 358 | BVS | Bioventus Inc. | 1.15B | 2.33% | 167,600 | 581.85M |
| 359 | TDOC | Teladoc Health, Inc. | 1.14B | -0.08% | 1,034,801 | 2.49B |
| 360 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | 5.15% | 337,643 | - |
| 361 | MLTX | MoonLake Immunotherapeutics | 1.09B | 2.07% | 1,221,066 | - |
| 362 | ODTX | Odyssey Therapeutics, Inc. | 1.09B | -1.56% | 319,656 | 99.00K |
| 363 | IRMD | IRADIMED CORPORATION | 1.09B | 2.91% | 85,036 | 86.34M |
| 364 | PRCT | PROCEPT BioRobotics Corporation | 1.08B | 1.89% | 407,745 | 337.34M |
| 365 | MNKD | MannKind Corporation | 1.08B | -4.14% | 11,931,232 | 393.63M |
| 366 | CSTL | Castle Biosciences, Inc. | 1.07B | 0.11% | 169,259 | 357.28M |
| 367 | JBIO | Jade Biosciences, Inc. | 1.07B | 0.36% | 355,446 | - |
| 368 | APMD | Apnimed, Inc. | 1.06B | -3.01% | 349,301 | 115.12M |
| 369 | JANX | Janux Therapeutics, Inc. | 1.05B | 1.29% | 177,918 | 24.00M |
| 370 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.05B | 0.94% | 185,982 | 730.02M |
| 371 | ENOV | Enovis Corporation | 1.05B | 0.83% | 537,554 | 2.30B |
| 372 | GLUE | Monte Rosa Therapeutics, Inc. | 1.05B | 0.08% | 555,470 | 28.73M |
| 373 | OBX | Obsidian Therapeutics, Inc. | 1.05B | -2.37% | 484,674 | - |
| 374 | KURA | Kura Oncology, Inc. | 1.04B | 1.21% | 678,486 | 77.23M |
| 375 | ANL | Adlai Nortye Group Ltd. | 1.04B | 3.98% | 41,851 | 18.06M |
| 376 | STAA | STAAR Surgical Company | 1.04B | 2.31% | 384,708 | 339.59M |
| 377 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | 0.19% | 240,207 | 1.04B |
| 378 | ALMS | Alumis Inc. | 1.02B | - | 1,135,754 | 7.40M |
| 379 | HELP | Cybin Inc. | 1.00B | 0.44% | 1,421,742 | - |
| 380 | ABUS | Arbutus Biopharma Corporation | 990.23M | 0.10% | 3,193,642 | 181.72M |
| 381 | PCRX | Pacira BioSciences, Inc. | 988.77M | 2.88% | 111,146 | 746.16M |
| 382 | SLBT | SL Science Holding Limited | 975.16M | -0.58% | 14,120 | 3.27M |
| 383 | SGP | SpyGlass Pharma, Inc. | 959.96M | 2.65% | 53,633 | - |
| 384 | SLDB | Solid Biosciences Inc. | 951.09M | 3.86% | 600,386 | - |
| 385 | SANA | Sana Biotechnology, Inc. | 942.99M | 1.61% | 2,389,585 | - |
| 386 | LXRX | Lexicon Pharmaceuticals, Inc. | 938.86M | 3.43% | 854,280 | 41.47M |
| 387 | CBLL | CeriBell, Inc. | 928.75M | -0.21% | 103,527 | 101.96M |
| 388 | ATTO | Attovia Therapeutics, Inc. | 922.16M | -5.16% | 90,817 | 1.80M |
| 389 | RIGL | Rigel Pharmaceuticals, Inc. | 897.85M | 2.07% | 65,479 | 276.79M |
| 390 | CADL | Candel Therapeutics, Inc. | 897.56M | 4.64% | 422,409 | - |
| 391 | HSTM | HealthStream, Inc. | 889.27M | -0.05% | 35,108 | 321.12M |
| 392 | FDMT | 4D Molecular Therapeutics, Inc. | 886.67M | 5.31% | 351,804 | 92.01M |
| 393 | TBPH | Theravance Biopharma, Inc. | 885.21M | - | 1,221,225 | 104.31M |
| 394 | IMMX | Immix Biopharma, Inc. | 882.80M | -1.04% | 380,986 | - |
| 395 | AVTX | Avalo Therapeutics, Inc. | 881.14M | 1.61% | 251,252 | 59.00K |
| 396 | ARDX | Ardelyx, Inc. | 877.14M | 0.57% | 1,402,419 | 450.89M |
| 397 | WVE | Wave Life Sciences, Inc. | 866.03M | 3.29% | 1,389,183 | 65.37M |
| 398 | ACHV | Achieve Life Sciences, Inc. | 858.21M | 3.60% | 700,228 | - |
| 399 | FTH | Faeth Therapeutics, Inc. | 856.61M | -0.42% | 216,007 | - |
| 400 | IVA | Inventiva S.A. | 850.92M | -2.33% | 1,121,363 | 7.94M |
| 401 | GMRS | GMR Solutions Inc. | 850.28M | -5.28% | 289,872 | 5.88B |
| 402 | OLMA | Olema Pharmaceuticals, Inc. | 843.48M | 0.10% | 646,512 | - |
| 403 | SIBN | SI-BONE, Inc. | 839.23M | 1.49% | 247,415 | 213.60M |
| 404 | GERN | Geron Corporation | 835.22M | - | 2,656,832 | 204.56M |
| 405 | INMD | InMode Ltd. | 830.88M | -0.31% | 156,956 | 374.63M |
| 406 | ETRA | Electra Therapeutics, Inc. | 828.52M | -5.17% | 257,957 | - |
| 407 | BLSM | BlossomHill Therapeutics, Inc. | 823.85M | 0.32% | 77,544 | - |
| 408 | ACRS | Aclaris Therapeutics, Inc. | 822.84M | 0.36% | 737,822 | 8.22M |
| 409 | DSGN | Design Therapeutics, Inc. | 813.56M | 3.59% | 166,334 | - |
| 410 | CLYM | Climb Bio, Inc. | 797.79M | 1.83% | 386,180 | - |
| 411 | ANNX | Annexon, Inc. | 795.28M | -0.59% | 740,226 | - |
| 412 | GYRE | Gyre Therapeutics, Inc. | 791.01M | 0.40% | 92,946 | 109.82M |
| 413 | AVR | Anteris Technologies Global Corp. | 786.98M | -0.92% | 282,636 | 2.24M |
| 414 | AHCO | AdaptHealth Corp. | 783.11M | 2.09% | 640,245 | 3.36B |
| 415 | VREX | Varex Imaging Corporation | 779.74M | 0.16% | 384,692 | 865.00M |
| 416 | GLAS | Glass House Brands Inc. | 756.77M | 1.13% | 520,395 | 176.98M |
| 417 | VSTM | Verastem, Inc. | 756.20M | 4.51% | 2,162,113 | 87.53M |
| 418 | QDEL | QuidelOrtho Corporation | 755.70M | 1.47% | 269,283 | 2.67B |
| 419 | PHAR | Pharming Group N.V. | 753.32M | 2.78% | 43,617 | 366.48M |
| 420 | COLL | Collegium Pharmaceutical, Inc. | 747.80M | -0.30% | 225,151 | 808.21M |
| 421 | NVCT | Nuvectis Pharma, Inc. | 745.79M | 4.14% | 51,645 | - |
| 422 | CTKB | Cytek Biosciences, Inc. | 742.20M | 8.14% | 797,831 | 206.71M |
| 423 | SLN | Silence Therapeutics plc | 741.78M | 0.57% | 240,490 | 615.00K |
| 424 | IRWD | Ironwood Pharmaceuticals, Inc. | 737.80M | 1.25% | 859,487 | 389.32M |
| 425 | DBVT | DBV Technologies S.A. | 723.58M | 0.12% | 133,393 | 5.04M |
| 426 | MDXG | MiMedx Group, Inc. | 714.23M | 1.87% | 372,303 | 355.17M |
| 427 | CBIO | Crescent Biopharma, Inc. | 706.21M | 1.54% | 56,495 | 11.88M |
| 428 | STLN | Starling Oncology, Inc. | 701.18M | 0.73% | 291,468 | 587.24M |
| 429 | SOPH | SOPHiA GENETICS SA | 696.35M | -0.73% | 201,842 | 86.17M |
| 430 | ZVRA | Zevra Therapeutics, Inc. | 691.82M | -0.17% | 188,265 | 136.07M |
| 431 | SGMT | Sagimet Biosciences Inc. | 691.20M | 2.96% | 561,417 | - |
| 432 | OABI | OmniAb, Inc. | 689.88M | 3.60% | 425,150 | 38.46M |
| 433 | NGNE | Neurogene Inc. | 670.38M | 2.86% | 800,611 | 925.00K |
| 434 | SSII | SS Innovations International, Inc. | 660.75M | 0.22% | 45,177 | 52.40M |
| 435 | AURA | Aura Biosciences, Inc. | 655.93M | -0.55% | 246,574 | - |
| 436 | AHG | Akso Health Group | 651.10M | - | 369 | 13.83M |
| 437 | ALT | Altimmune, Inc. | 650.66M | 2.29% | 2,545,360 | 31.00K |
| 438 | OCS | Oculis Holding AG | 650.66M | 3.94% | 92,529 | 1.45M |
| 439 | ANGO | AngioDynamics, Inc. | 646.03M | 1.36% | 116,897 | 320.17M |
| 440 | STTK | Shattuck Labs, Inc. | 635.80M | 3.68% | 369,083 | 1.00M |
| 441 | MNPR | Monopar Therapeutics Inc. | 634.84M | -1.19% | 58,198 | - |
| 442 | AQST | Aquestive Therapeutics, Inc. | 628.19M | 4.71% | 1,260,116 | 54.09M |
| 443 | PHR | Phreesia, Inc. | 627.54M | 0.80% | 184,814 | 507.79M |
| 444 | VALN | Valneva SE | 620.56M | -0.23% | 7,617 | 163.30M |
| 445 | PHAT | Phathom Pharmaceuticals, Inc. | 612.41M | 3.49% | 902,769 | 239.66M |
| 446 | CTMX | CytomX Therapeutics, Inc. | 611.21M | 1.63% | 3,553,797 | 18.30M |
| 447 | CRMD | CorMedix Inc. | 607.19M | 0.26% | 284,774 | 462.25M |
| 448 | PRME | Prime Medicine, Inc. | 604.87M | 6.58% | 1,374,355 | 4.07M |
| 449 | DNA | Ginkgo Bioworks Holdings, Inc. | 600.00M | 11.65% | 1,593,422 | 132.42M |
| 450 | KIDS | OrthoPediatrics Corp. | 596.09M | 2.15% | 47,919 | 252.72M |
| 451 | FLGT | Fulgent Genetics, Inc. | 595.43M | 0.46% | 99,191 | 323.93M |
| 452 | MPLT | MapLight Therapeutics, Inc. | 594.10M | -1.93% | 150,032 | - |
| 453 | DRUG | Bright Minds Biosciences Inc. | 593.40M | 2.51% | 33,927 | - |
| 454 | ALLO | Allogene Therapeutics, Inc. | 589.06M | 0.89% | 2,475,218 | 4.64M |
| 455 | WEAV | Weave Communications, Inc. | 587.19M | 0.27% | 1,411,021 | 257.79M |
| 456 | TLRY | Tilray Brands, Inc. | 584.95M | 4.66% | 2,924,929 | 915.45M |
| 457 | AGMB | AgomAb Therapeutics NV | 573.74M | -0.43% | 30,502 | - |
| 458 | EVO | Evotec SE | 569.60M | 1.62% | 93,678 | 819.47M |
| 459 | EPRX | Eupraxia Pharmaceuticals Inc. | 568.75M | -0.81% | 333,058 | - |
| 460 | DCTH | Delcath Systems, Inc. | 559.69M | 0.12% | 136,273 | 95.42M |
| 461 | PROK | ProKidney Corp. | 554.76M | 3.38% | 392,553 | 818.00K |
| 462 | ARVN | Arvinas, Inc. | 551.86M | 1.69% | 258,579 | 316.70M |
| 463 | CAPR | Capricor Therapeutics, Inc. | 546.51M | 5.62% | 1,531,309 | 11.13M |
| 464 | OVID | Ovid Therapeutics Inc. | 544.88M | 2.95% | 720,436 | 1.58M |
| 465 | EOLS | Evolus, Inc. | 540.29M | 2.38% | 174,977 | 316.49M |
| 466 | BWAY | BrainsWay Ltd. | 538.81M | -0.52% | 94,665 | 60.70M |
| 467 | SCTX | Scribe Therapeutics Inc. | 536.76M | 1.08% | 398,858 | 33.30M |
| 468 | AUTL | Autolus Therapeutics plc | 534.99M | 3.61% | 861,488 | 117.39M |
| 469 | RGNX | REGENXBIO Inc. | 534.71M | 2.79% | 577,076 | 174.48M |
| 470 | CERS | Cerus Corporation | 525.98M | 1.95% | 1,378,010 | 221.55M |
| 471 | SENS | Senseonics Holdings, Inc. | 520.28M | 0.61% | 245,079 | 48.55M |
| 472 | TECX | Tectonic Therapeutic, Inc. | 519.82M | -0.15% | 64,420 | - |
| 473 | TCMD | Tactile Systems Technology, Inc. | 516.70M | -0.18% | 172,418 | 350.31M |
| 474 | ENTX | Entera Bio Ltd. | 514.23M | 0.34% | 207,356 | 42.00K |
| 475 | CTNM | Contineum Therapeutics, Inc. | 512.59M | 0.55% | 292,636 | - |
| 476 | ASMB | Assembly Biosciences, Inc. | 511.87M | -1.18% | 429,642 | 74.85M |
| 477 | PBYI | Puma Biotechnology, Inc. | 508.46M | 2.71% | 179,988 | 231.24M |
| 478 | NPCE | NeuroPace, Inc. | 508.00M | 1.79% | 43,324 | 106.99M |
| 479 | INDP | Indaptus Therapeutics, Inc. | 504.99M | 22.65% | 866,742 | - |
| 480 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 481 | KMDA | Kamada Ltd. | 501.36M | 0.77% | 75,958 | 191.85M |
| 482 | CTEV | Claritev Corporation | 498.93M | -6.89% | 56,444 | 994.67M |
| 483 | PRLD | Prelude Therapeutics Incorporated | 493.86M | 2.02% | 233,084 | 22.42M |
| 484 | EIKN | Eikon Therapeutics, Inc. | 489.65M | 2.38% | 128,272 | - |
| 485 | NRC | NRC Health | 479.77M | 1.97% | 54,083 | 140.00M |
| 486 | TKNO | Alpha Teknova, Inc. | 477.83M | 6.71% | 205,318 | 43.70M |
| 487 | SRTA | Strata Critical Medical, Inc. | 473.74M | -0.83% | 195,845 | 255.98M |
| 488 | SGHT | Sight Sciences, Inc. | 464.94M | -0.59% | 91,244 | 83.38M |
| 489 | KYTX | Kyverna Therapeutics, Inc. | 463.83M | 5.34% | 468,163 | - |
| 490 | PRTA | Prothena Corporation plc | 455.62M | 4.29% | 194,222 | 54.53M |
| 491 | MASS | 908 Devices Inc. | 453.43M | 0.83% | 158,328 | 60.84M |
| 492 | CLPT | ClearPoint Neuro, Inc. | 452.67M | 6.22% | 340,491 | 42.28M |
| 493 | PACB | Pacific Biosciences of California, Inc. | 452.26M | 6.99% | 4,623,102 | 159.27M |
| 494 | RLMD | Relmada Therapeutics, Inc. | 450.15M | 1.44% | 283,254 | - |
| 495 | AVIR | Atea Pharmaceuticals, Inc. | 447.14M | 2.67% | 66,201 | - |
| 496 | SPRY | ARS Pharmaceuticals, Inc. | 440.55M | 1.84% | 613,623 | 116.93M |
| 497 | TTRX | Turn Therapeutics Inc. | 438.93M | -3.94% | 49,273 | - |
| 498 | EDIT | Editas Medicine, Inc. | 438.47M | 0.88% | 1,154,540 | 47.01M |
| 499 | CARL | Carlsmed, Inc. | 432.75M | 1.60% | 19,296 | 63.30M |
| 500 | ZURA | Zura Bio Limited | 429.31M | -0.44% | 1,059,275 | - |